Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea.

MLA

Choi, Su Jin, et al. “Anti-Tumor Necrosis Factor-Induced Lupus in Patients with Inflammatory Bowel Disease: A Hospital-Based Cohort Study from Korea.” Therapeutic Advances in Gastroenterology, vol. 14, Mar. 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1177/1756284821997794.

APA

Choi, S. J., Ahn, S. M., Oh, J. S., Hong, S., Lee, C.-K., Yoo, B., Ye, B. D., Yang, S.-K., Park, S. H., & Kim, Y.-G. (2021). Anti-tumor necrosis factor-induced lupus in patients with inflammatory bowel disease: a hospital-based cohort study from Korea. Therapeutic Advances in Gastroenterology, 14, 1–9. https://doi.org/10.1177/1756284821997794

Chicago

Choi, Su Jin, Soo Min Ahn, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Byong Duk Ye, Suk-Kyun Yang, Sang Hyoung Park, and Yong-Gil Kim. 2021. “Anti-Tumor Necrosis Factor-Induced Lupus in Patients with Inflammatory Bowel Disease: A Hospital-Based Cohort Study from Korea.” Therapeutic Advances in Gastroenterology 14 (March): 1–9. doi:10.1177/1756284821997794.